Cutler Group’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,100
Closed -$12K 2302
2023
Q4
$12K Sell
2,100
-22,050
-91% -$2.87M ﹤0.01% 2273
2023
Q3
$30K Buy
24,150
+16,650
+222% +$2.27M ﹤0.01% 1764
2023
Q2
$7K Buy
+7,500
New +$1.1M ﹤0.01% 2419
2023
Q1
Sell
-10,250
Closed -$14K 3782
2022
Q4
$14K Sell
10,250
-2,900
-22% -$364K ﹤0.01% 2456
2022
Q3
$7K Sell
13,150
-5,350
-29% -$679K ﹤0.01% 3357
2022
Q2
$72K Sell
18,500
-15,850
-46% -$2.08M 0.01% 1664
2022
Q1
$170K Buy
+34,350
New +$4.12M 0.01% 1308
2021
Q4
Sell
-500
Closed -$1K 5362
2021
Q3
$1K Sell
500
-2,000
-80% -$233K ﹤0.01% 5229
2021
Q2
$27K Buy
+2,500
New +$274K ﹤0.01% 3036
2019
Q1
Sell
-22,500
Closed -$84K 4015
2018
Q4
$84K Hold
22,500
0.01% 1141
2018
Q3
$166K Hold
22,500
0.01% 926
2018
Q2
$68K Sell
22,500
-2,500
-10% -$180K 0.01% 1405
2018
Q1
$98K Sell
25,000
-7,100
-22% -$492K 0.01% 1192
2017
Q4
$104K Buy
32,100
+3,550
+12% +$239K ﹤0.01% 1345
2017
Q3
$108K Sell
28,550
-37,900
-57% -$2.39M ﹤0.01% 1614
2017
Q2
$418K Buy
66,450
+12,500
+23% +$816K 0.02% 799
2017
Q1
$148K Buy
53,950
+26,950
+100% +$1.57M 0.01% 1409
2016
Q4
$67K Sell
27,000
-6,400
-19% -$363K ﹤0.01% 2269
2016
Q3
$130K Buy
33,400
+5,950
+22% +$389K 0.01% 1593
2016
Q2
$43K Sell
27,450
-5,200
-16% -$302K ﹤0.01% 2501
2016
Q1
$40K Sell
32,650
-23,850
-42% -$1.43M ﹤0.01% 2547
2015
Q4
$153K Buy
+56,500
New +$3.7M 0.01% 1396

Other funds holding AZN